Ideaya Biosciences

IDEAYA is a clinical-stage oncology-focused biotechnology company committed to the discovery and development of personalized therapeutics. We are using deep translational biology expertise to pursue cancers using multiple mechanistic approaches, including targeted therapies directly targeting tumor genomic susceptibilities, synthetic lethality medicines for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. Founded in 2015, the Company has assembled a world-class drug discovery and development team and a Scientific Advisory Board (SAB) which consists of industry thought leaders including members of the National Academy of Sciences and the National Academy of Medicine. IDEAYA is headquartered in South San Francisco, California.